期刊文献+

胃癌骨髓转移的血液学特征和治疗方式探讨 被引量:6

Hematological characteristics and treatment strategy of bone marrow metastasis in gastric cancer
下载PDF
导出
摘要 目的探讨胃癌骨髓转移患者的临床病理特征、治疗及预后。方法回顾性分析9例胃癌骨髓转移患者的临床资料,总结其临床特点、诊断和治疗方法。结果 9例患者的年龄为18~68岁,中位年龄为51岁,病理均为低分化腺癌。患者均伴有其他部位转移,常见淋巴结和骨转移。骨痛、非感染性发热、红细胞和血小板二系下降、碱性磷酸酶和(或)乳酸脱氢酶不同程度升高、外周血涂片可见幼稚细胞是胃癌骨髓转移的常见表现。胃癌骨髓转移患者的中位生存期为34 d(11~266 d)。结论胃癌骨髓转移患者的预后差,熟悉胃癌骨髓转移的临床特点有利于早期诊断。 Objective To investigate the clinicopathologic feature, treatment strategies and prognosis of gastric cancer patients with bone marrow metastasis. Method The clinical profile of 9 gastric cancer patients with bone marrow metastasis were analyzed retrospectively. The clinicopathological characteristics, diagnosis and treatment methods were summarized. Result The age of the 9 patients was 18-68(median: 51) and the histological types of all cases were poorly differentiated adenocarcinoma. Disseminated organ metastases were observed in all cases, and most were in distant lymph nodes and bone. Common clinical manifestations of bone marrow metastasis were bone pain, non-infective fever, decrease of 2 indexes in hemogram, increase of alkaline phosphatase and lactate dehydrogenase, immature cells in peripheral blood smears. The median overall survival time of the patients was 34 days(11-266 days). Conclusion The prognosis of gastric cancer patients with bone marrow metastasis was poor. An in-depth understanding of the clinical features of these rare metastases may help discover the metastasis in the early stage.
出处 《癌症进展》 2017年第6期705-708,共4页 Oncology Progress
基金 北京市自然科学基金(7162164) 首都卫生发展科研专项(首发2014-4-4028)
关键词 骨髓转移 胃癌 治疗 预后 bone marrow metastasis gastric cancer treatment prognosis
  • 相关文献

参考文献2

二级参考文献28

  • 1Japanese Classification of Gastric Carcinoma – 2nd English Edition –[J]. Gastric Cancer . 1998 (1)
  • 2Wasaburo Koizumi,Hiroyuki Narahara,Takuo Hara,Akinori Takagane,Toshikazu Akiya,Masakazu Takagi,Kosei Miyashita,Takashi Nishizaki,Osamu Kobayashi,Wataru Takiyama,Yasushi Toh,Takashi Nagaie,Seiichi Takagi,Yoshitaka Yamamura,Kimihiko Yanaoka,Hiroyuki Orita,Masahiro Takeuchi.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial[J]. Lancet Oncology . 2008 (3)
  • 3Florian Lordick,Yoon-Koo Kang,Hyun-Cheol Chung,Pamela Salman,Sang Cheul Oh,Gy?rgy Bodoky,Galina Kurteva,Constantin Volovat,Vladimir M Moiseyenko,Vera Gorbunova,Joon Oh Park,Akira Sawaki,Ilhan Celik,Heiko G?tte,Helena Melezínková,Markus Moehler.Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6)
  • 4Narikazu Boku,Seiichiro Yamamoto,Haruhiko Fukuda,Kuniaki Shirao,Toshihiko Doi,Akira Sawaki,Wasaburo Koizumi,Hiroshi Saito,Kensei Yamaguchi,Hiroya Takiuchi,Junichiro Nasu,Atsushi Ohtsu.Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study[J].Lancet Oncology.2009(11)
  • 5Humar Bostjan,Blair Vanessa,Charlton Amanda,More Helen,Martin Iain,Guilford Parry.E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Research . 2009
  • 6Rebecca Aft,Jose-Ricardo Perez,Noopur Raje,Vera Hirsh,Fred Saad.Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates[J]. Critical Reviews in Oncology / Hematology . 2011 (2)
  • 7Xin Lu,Euphemia Mu,Yong Wei,Sabine Riethdorf,Qifeng Yang,Min Yuan,Jun Yan,Yuling Hua,Benjamin J. Tiede,Xuemin Lu,Bruce G. Haffty,Klaus Pantel,Joan Massagué,Yibin Kang.VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors[J]. Cancer Cell . 2011 (6)
  • 8Hiroki Kusumoto,Masaru Haraguchi,Yoko Nozuka,Yoshinao Oda,Masazumi Tsuneyoshi,Haruo Iguchi.Characteristic features of disseminated carcinomatosis of the bone marrowdue to gastric cancer: The pathogenesis of bone destruction[J]. Oncology Reports . 2006 (4)
  • 9Neslihan Cabioglu,Aysegul Sahin,Michele Doucet,Ekrem Yavuz,Abdullah Igci,Engin O.Yildirim,Esin Aktas,Sema Bilgic,Bayram Kiran,Gunnur Deniz,Janet E. Price.Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow[J]. Clinical & Experimental Metastasis . 2005 (1)
  • 10Toshiyuki Yoneda,Toru Hiraga.Crosstalk between cancer cells and bone microenvironment in bone metastasis[J]. Biochemical and Biophysical Research Communications . 2004 (3)

共引文献323

同被引文献53

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部